EW vs. NVNO

In the year-to-date period, EW achieves a 5.36% return, which is significantly lower than NVNO's 19.87% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and enVVeno Medical Corporation (NVNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current EW Sharpe Ratio is -0.33, which is comparable to the NVNO Sharpe Ratio of -0.41. The chart below compares the historical Sharpe Ratios of EW and NVNO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither EW nor NVNO has paid dividends to shareholders.

The maximum EW drawdown since its inception was -54.32%, smaller than the maximum NVNO drawdown of -98.38%. Use the drawdown chart below to compare losses from any high point for EW and NVNO. For additional features, visit the drawdowns tool.

The current volatility for Edwards Lifesciences Corporation (EW) is 8.41%, while enVVeno Medical Corporation (NVNO) has a volatility of 19.56%. This indicates that EW experiences smaller price fluctuations and is considered to be less risky than NVNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Edwards Lifesciences Corporation and enVVeno Medical Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.